Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Oragenics Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 33 | 28 | −5 |
| Shares | 11.1M | 10.5M | −605.5K (−5.4%) |
| Value | $4.96M | $3.62M | −$1.34M (−27.1%) |
New holders (1)
Institutions that held Oragenics Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Glassman Wealth Services | 1 | $0 | 0.00% |
Sold out (6)
Institutions that held Oragenics Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 410,944 | $183.0K |
| Price T Rowe Associates Inc | 79,700 | $36.0K |
| Citadel Advisors LLC | 54,375 | $24.0K |
| Holloway Wealth Management, LLC | – | $1.00K |
| Bank of America Corp | 115 | $0 |
| Cornerstone Advisory, LLC | 25 | $0 |